Home › NDC Lookup › RxCUI directory › RxCUI 2119391

{2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 56 MG Dose Kit] — RxCUI 2119391

RxNorm drug concept · Brand name pack
RxCUI 2119391 Brand name pack · BPCK ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2119391
Official name{2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 56 MG Dose Kit]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asSpravato 56 MG Dose Kit
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)184,743 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Esketamine Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — Spravato cannot be taken at home, and that's a firm rule, not just a suggestion. Because it can cause heavy sedation, a dreamlike detachment from reality (called dissociation)...
  • Why do I have to go to a clinic every time I use this? Can I take it at home?
  • Dissociation is when you feel detached from yourself or your surroundings — time might feel distorted, things might look or sound different, or you might feel like you're watching...
  • What does 'dissociation' actually feel like, and is it dangerous?
📖 Read our full Esketamine Nasal Spray guide →

🕸️ Concept Web — How {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [S... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 56 MG Dose Kit] RxCUI 2119391

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Esketamine 2119365
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Spravato 2119382
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Esketamine Nasal Spray 2201623
    • Esketamine Inhalant Product 2119378
    • Esketamine Nasal Product 2119379
    • Esketamine Nasal Spray [Spravato] 2201625
    • Spravato Inhalant Product 2119385
    • Spravato Nasal Product 2119386
    • Pack 746839
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Esketamine 140 MG/ML Nasal Spray [Spravato] SBD · 2119387
  • Esketamine 140 MG/ML [Spravato] SBDC · 2119383
  • Esketamine Nasal Spray [Spravato] SBDF · 2201625
  • Spravato Inhalant Product SBDG · 2119385
  • Spravato Nasal Product SBDG · 2119386
  • Spravato BN · 2119382

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2119391 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50458-0028-02 2 BLISTER PACK in 1 KIT (50458-028-02) / 1 VIAL, SINGLE-USE... Spravato Janssen Pharmaceuticals Inc. 2019-03-05
50458-0028-03 3 BLISTER PACK in 1 KIT (50458-028-03) / 1 VIAL, SINGLE-USE... Spravato Janssen Pharmaceuticals Inc. 2019-03-05
Observed labelers: Janssen Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$427.8655
Range $426.2990–$429.4320 · middle 50% $427.0823–$428.6488 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.